Publications
- The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients2014 | First Faculty of Medicine, Second Faculty of Medicine
- A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase II alpha, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma2010 | Second Faculty of Medicine
- Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma2010 | Second Faculty of Medicine
- Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders2008 | Second Faculty of Medicine
- Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma2008 | Second Faculty of Medicine
- Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients2008 | Second Faculty of Medicine
- Individual differences of taxol pharmacokinetics in breast cancer patients2007 | Second Faculty of Medicine
- Expression of multidrug resistance gene 1 (MDR1) and its association with development and clinical outcome of breast carcinoma2007 | Second Faculty of Medicine
- RNA expression of cytochrome P450 in breast cancer patients2007 | Second Faculty of Medicine
- Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization2003 | Second Faculty of Medicine
Loading network view...